• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS, INC. ADVIA CENTAUR XP ANTI-HBS2 (AHBS2); AHBS2 IMMUNOASSAY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS, INC. ADVIA CENTAUR XP ANTI-HBS2 (AHBS2); AHBS2 IMMUNOASSAY Back to Search Results
Model Number N/A
Device Problem No Apparent Adverse Event (3189)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 03/11/2019
Event Type  malfunction  
Manufacturer Narrative
A siemens field service engineer went on site and completed contamination testing, wash dispense and aspirate testing, cleaned the wash block, completed dispense tests to visually observe proper dispensing, checked the acid and base dispense and adjusted volume to 3 ml, verified proper alignment of reagent probe 3 and adjusted cuvette bottom settings to 2 steps.On another visit, decontamination of the acid and base was performed using cleaning solution.New reservoirs, gaskets and bulk acid and base bottles were installed.Background testing and dark counts testing were performed.The ahbs2 assay was calibrated and qc testing was performed.Calibration and qc passed.Siemens continues to investigate.The interpretation of results section of the instructions for use states: "results should always be interpreted in conjunction with the patient's medical history, clinical presentation, and other findings.".
 
Event Description
Customer observed an advia centaur xp anti-hbs2 (ahbs2) result that was elevated and (b)(6) and did not match the clinical picture of the patient.The physician questioned the result.There are no reports that treatment was altered or prescribed or adverse health consequences due to the elevated advia centaur xp ahbs2 result.
 
Manufacturer Narrative
Mdr 1219913-2019-00056 was filed reporting an elevated advia centaur xp anti-hbs2 result that did not match the clinical picture of the patient.Additional information - may 23, 2019 while the issue was corrected by performing the acid and base decontamination, the cause of the contamination was not determined.The system is now performing as designed.Root cause of the imprecision with advia centaur xp ahbs2 lot 102 was an issue resolved with normal instrument troubleshooting.Based on the investigation, no product problem was identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ADVIA CENTAUR XP ANTI-HBS2 (AHBS2)
Type of Device
AHBS2 IMMUNOASSAY
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS, INC.
511 benedict avenue
tarrytown NY 10591
MDR Report Key8554623
MDR Text Key161590894
Report Number1219913-2019-00056
Device Sequence Number1
Product Code LOM
UDI-Device Identifier00630414591407
UDI-Public00630414591407
Combination Product (y/n)N
PMA/PMN Number
P100039
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,user faci
Remedial Action Inspection
Type of Report Initial,Followup
Report Date 06/12/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/21/2020
Device Model NumberN/A
Device Catalogue Number10698706
Device Lot Number102
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 04/03/2019
Initial Date FDA Received04/26/2019
Supplement Dates Manufacturer Received05/23/2019
Supplement Dates FDA Received06/12/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-